DadFinStart your free week
DadFin › Stocks › Healthcare › CHE

Chemed Corporation (CHE) stock score

Healthcare · Medical Care Facilities · United States

$499.82 ▲ +0.32% today

82.9
Dad Score, out of 100
good

Chemed Corporation (CHE) is a Medical Care Facilities company in the Healthcare sector, listed in the United States. On DadFin's weekly run it scores 82.9 out of 100 on the Dad Score, a good reading that places the business ahead of 83% of the 5,774 US and Canadian stocks DadFin fully scores. Inside Healthcare it ranks #151 of 974. Its strongest axes are valuation, price action and liquidity; its weakest are risk and conviction.

Scores from the run of Oct 4, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →

The eight axes

Valuation
Strong
Quality
Average
Growth
Average
Price action
Above average
Risk
Below average
Conviction
Below average
Liquidity
Strong
Macro
Above average

Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.

Key numbers

P/E (trailing)25.3×
P/E (forward)18.4×
Dividend yield0.48%
Return on capital28.6%
Operating margin13.2%
Revenue growth (YoY)+4.1%
FCF yield5.0%
Net debt / EBITDA0.61×
Piotroski F-Score5 / 9
52-week change+17.2%
Market cap$6.6B
Next earningsOct 27, 2026

What subscribers see on CHE

Start your free weekSubscriber? Open the full research →

Medical Care Facilities peers

StockCompanyDad ScoreBandMarket cap
HCAHCA Healthcare, Inc.94.4strong$94.7B
THCTenet Healthcare Corporation85.2strong$20.8B
FMSFresenius Medical Care AG64.4middling$11.8B
EHCEncompass Health Corporation90.0strong$11.8B
DVADaVita Inc.70.5good$11.5B
UHSUniversal Health Services, Inc.96.7strong$10.4B
ENSGThe Ensign Group, Inc.78.9good$10.0B
PACSPACS Group, Inc.82.5good$6.8B

Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 4, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.